- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The DNA Diagnostics/Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global DNA Diagnostics/Testing market size is estimated to be worth US$ 24690 million in 2021 and is forecast to a readjusted size of USD 41740 million by 2028 with a CAGR of 7.8% during review period. Oncology Diagnostics & Histopathology accounting for % of the DNA Diagnostics/Testing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While PCR Based Diagnostics segment is altered to a % CAGR between 2022 and 2028.
Global key companies of DNA Diagnostics/Testing include Abbott Laboratories, Affymetrix Inc., Agilent Technologies Inc, Applied Biosystems Group, and Illumina Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
DNA Diagnostics/Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
PCR Based Diagnostics
NGS DNA Diagnosis
In-situ Hybridization Diagnostics
Micro-arrays Based Diagnostics
Market segment by Application, can be divided into
Oncology Diagnostics & Histopathology
Identity Diagnostics & Forensics
Pharmacogenomics Diagnostic Testing & Drug Metabolism
Market segment by players, this report covers
Abbott Laboratories
Affymetrix Inc.
Agilent Technologies Inc
Applied Biosystems Group
Illumina Inc.
Cepheid Inc.
Hologic
Bio-Rad Laboratories
Dako
Abbott
Roche Diagnostics
Beckman Coulter Inc.
Siemens Healthcare
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe DNA Diagnostics/Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of DNA Diagnostics/Testing, with revenue, gross margin and global market share of DNA Diagnostics/Testing from 2019 to 2022.
Chapter 3, the DNA Diagnostics/Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and DNA Diagnostics/Testing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe DNA Diagnostics/Testing research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of DNA Diagnostics/Testing
1.2 Classification of DNA Diagnostics/Testing by Type
1.2.1 Overview: Global DNA Diagnostics/Testing Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global DNA Diagnostics/Testing Revenue Market Share by Type in 2021
1.2.3 PCR Based Diagnostics
1.2.4 NGS DNA Diagnosis
1.2.5 In-situ Hybridization Diagnostics
1.2.6 Micro-arrays Based Diagnostics
1.3 Global DNA Diagnostics/Testing Market by Application
1.3.1 Overview: Global DNA Diagnostics/Testing Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oncology Diagnostics & Histopathology
1.3.3 Identity Diagnostics & Forensics
1.3.4 Pharmacogenomics Diagnostic Testing & Drug Metabolism
1.4 Global DNA Diagnostics/Testing Market Size & Forecast
1.5 Global DNA Diagnostics/Testing Market Size and Forecast by Region
1.5.1 Global DNA Diagnostics/Testing Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global DNA Diagnostics/Testing Market Size by Region, (2017-2022)
1.5.3 North America DNA Diagnostics/Testing Market Size and Prospect (2017-2028)
1.5.4 Europe DNA Diagnostics/Testing Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific DNA Diagnostics/Testing Market Size and Prospect (2017-2028)
1.5.6 South America DNA Diagnostics/Testing Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa DNA Diagnostics/Testing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 DNA Diagnostics/Testing Market Drivers
1.6.2 DNA Diagnostics/Testing Market Restraints
1.6.3 DNA Diagnostics/Testing Trends Analysis
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories DNA Diagnostics/Testing Product and Solutions
2.1.4 Abbott Laboratories DNA Diagnostics/Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Affymetrix Inc.
2.2.1 Affymetrix Inc. Details
2.2.2 Affymetrix Inc. Major Business
2.2.3 Affymetrix Inc. DNA Diagnostics/Testing Product and Solutions
2.2.4 Affymetrix Inc. DNA Diagnostics/Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Affymetrix Inc. Recent Developments and Future Plans
2.3 Agilent Technologies Inc
2.3.1 Agilent Technologies Inc Details
2.3.2 Agilent Technologies Inc Major Business
2.3.3 Agilent Technologies Inc DNA Diagnostics/Testing Product and Solutions
2.3.4 Agilent Technologies Inc DNA Diagnostics/Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Agilent Technologies Inc Recent Developments and Future Plans
2.4 Applied Biosystems Group
2.4.1 Applied Biosystems Group Details
2.4.2 Applied Biosystems Group Major Business
2.4.3 Applied Biosystems Group DNA Diagnostics/Testing Product and Solutions
2.4.4 Applied Biosystems Group DNA Diagnostics/Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Applied Biosystems Group Recent Developments and Future Plans
2.5 Illumina Inc.
2.5.1 Illumina Inc. Details
2.5.2 Illumina Inc. Major Business
2.5.3 Illumina Inc. DNA Diagnostics/Testing Product and Solutions
2.5.4 Illumina Inc. DNA Diagnostics/Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Illumina Inc. Recent Developments and Future Plans
2.6 Cepheid Inc.
2.6.1 Cepheid Inc. Details
2.6.2 Cepheid Inc. Major Business
2.6.3 Cepheid Inc. DNA Diagnostics/Testing Product and Solutions
2.6.4 Cepheid Inc. DNA Diagnostics/Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Cepheid Inc. Recent Developments and Future Plans
2.7 Hologic
2.7.1 Hologic Details
2.7.2 Hologic Major Business
2.7.3 Hologic DNA Diagnostics/Testing Product and Solutions
2.7.4 Hologic DNA Diagnostics/Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Hologic Recent Developments and Future Plans
2.8 Bio-Rad Laboratories
2.8.1 Bio-Rad Laboratories Details
2.8.2 Bio-Rad Laboratories Major Business
2.8.3 Bio-Rad Laboratories DNA Diagnostics/Testing Product and Solutions
2.8.4 Bio-Rad Laboratories DNA Diagnostics/Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.9 Dako
2.9.1 Dako Details
2.9.2 Dako Major Business
2.9.3 Dako DNA Diagnostics/Testing Product and Solutions
2.9.4 Dako DNA Diagnostics/Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Dako Recent Developments and Future Plans
2.10 Abbott
2.10.1 Abbott Details
2.10.2 Abbott Major Business
2.10.3 Abbott DNA Diagnostics/Testing Product and Solutions
2.10.4 Abbott DNA Diagnostics/Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Abbott Recent Developments and Future Plans
2.11 Roche Diagnostics
2.11.1 Roche Diagnostics Details
2.11.2 Roche Diagnostics Major Business
2.11.3 Roche Diagnostics DNA Diagnostics/Testing Product and Solutions
2.11.4 Roche Diagnostics DNA Diagnostics/Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Roche Diagnostics Recent Developments and Future Plans
2.12 Beckman Coulter Inc.
2.12.1 Beckman Coulter Inc. Details
2.12.2 Beckman Coulter Inc. Major Business
2.12.3 Beckman Coulter Inc. DNA Diagnostics/Testing Product and Solutions
2.12.4 Beckman Coulter Inc. DNA Diagnostics/Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Beckman Coulter Inc. Recent Developments and Future Plans
2.13 Siemens Healthcare
2.13.1 Siemens Healthcare Details
2.13.2 Siemens Healthcare Major Business
2.13.3 Siemens Healthcare DNA Diagnostics/Testing Product and Solutions
2.13.4 Siemens Healthcare DNA Diagnostics/Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Siemens Healthcare Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global DNA Diagnostics/Testing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 DNA Diagnostics/Testing Players Market Share in 2021
3.2.2 Top 10 DNA Diagnostics/Testing Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 DNA Diagnostics/Testing Players Head Office, Products and Services Provided
3.4 DNA Diagnostics/Testing Mergers & Acquisitions
3.5 DNA Diagnostics/Testing New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global DNA Diagnostics/Testing Revenue and Market Share by Type (2017-2022)
4.2 Global DNA Diagnostics/Testing Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global DNA Diagnostics/Testing Revenue Market Share by Application (2017-2022)
5.2 Global DNA Diagnostics/Testing Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America DNA Diagnostics/Testing Revenue by Type (2017-2028)
6.2 North America DNA Diagnostics/Testing Revenue by Application (2017-2028)
6.3 North America DNA Diagnostics/Testing Market Size by Country
6.3.1 North America DNA Diagnostics/Testing Revenue by Country (2017-2028)
6.3.2 United States DNA Diagnostics/Testing Market Size and Forecast (2017-2028)
6.3.3 Canada DNA Diagnostics/Testing Market Size and Forecast (2017-2028)
6.3.4 Mexico DNA Diagnostics/Testing Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe DNA Diagnostics/Testing Revenue by Type (2017-2028)
7.2 Europe DNA Diagnostics/Testing Revenue by Application (2017-2028)
7.3 Europe DNA Diagnostics/Testing Market Size by Country
7.3.1 Europe DNA Diagnostics/Testing Revenue by Country (2017-2028)
7.3.2 Germany DNA Diagnostics/Testing Market Size and Forecast (2017-2028)
7.3.3 France DNA Diagnostics/Testing Market Size and Forecast (2017-2028)
7.3.4 United Kingdom DNA Diagnostics/Testing Market Size and Forecast (2017-2028)
7.3.5 Russia DNA Diagnostics/Testing Market Size and Forecast (2017-2028)
7.3.6 Italy DNA Diagnostics/Testing Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific DNA Diagnostics/Testing Revenue by Type (2017-2028)
8.2 Asia-Pacific DNA Diagnostics/Testing Revenue by Application (2017-2028)
8.3 Asia-Pacific DNA Diagnostics/Testing Market Size by Region
8.3.1 Asia-Pacific DNA Diagnostics/Testing Revenue by Region (2017-2028)
8.3.2 China DNA Diagnostics/Testing Market Size and Forecast (2017-2028)
8.3.3 Japan DNA Diagnostics/Testing Market Size and Forecast (2017-2028)
8.3.4 South Korea DNA Diagnostics/Testing Market Size and Forecast (2017-2028)
8.3.5 India DNA Diagnostics/Testing Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia DNA Diagnostics/Testing Market Size and Forecast (2017-2028)
8.3.7 Australia DNA Diagnostics/Testing Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America DNA Diagnostics/Testing Revenue by Type (2017-2028)
9.2 South America DNA Diagnostics/Testing Revenue by Application (2017-2028)
9.3 South America DNA Diagnostics/Testing Market Size by Country
9.3.1 South America DNA Diagnostics/Testing Revenue by Country (2017-2028)
9.3.2 Brazil DNA Diagnostics/Testing Market Size and Forecast (2017-2028)
9.3.3 Argentina DNA Diagnostics/Testing Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa DNA Diagnostics/Testing Revenue by Type (2017-2028)
10.2 Middle East & Africa DNA Diagnostics/Testing Revenue by Application (2017-2028)
10.3 Middle East & Africa DNA Diagnostics/Testing Market Size by Country
10.3.1 Middle East & Africa DNA Diagnostics/Testing Revenue by Country (2017-2028)
10.3.2 Turkey DNA Diagnostics/Testing Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia DNA Diagnostics/Testing Market Size and Forecast (2017-2028)
10.3.4 UAE DNA Diagnostics/Testing Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global DNA Diagnostics/Testing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global DNA Diagnostics/Testing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market DNA Diagnostics/Testing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global DNA Diagnostics/Testing Revenue (USD Million) by Region (2017-2022)
Table 5. Global DNA Diagnostics/Testing Revenue Market Share by Region (2023-2028)
Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Laboratories Major Business
Table 8. Abbott Laboratories DNA Diagnostics/Testing Product and Solutions
Table 9. Abbott Laboratories DNA Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Affymetrix Inc. Corporate Information, Head Office, and Major Competitors
Table 11. Affymetrix Inc. Major Business
Table 12. Affymetrix Inc. DNA Diagnostics/Testing Product and Solutions
Table 13. Affymetrix Inc. DNA Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Agilent Technologies Inc Corporate Information, Head Office, and Major Competitors
Table 15. Agilent Technologies Inc Major Business
Table 16. Agilent Technologies Inc DNA Diagnostics/Testing Product and Solutions
Table 17. Agilent Technologies Inc DNA Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Applied Biosystems Group Corporate Information, Head Office, and Major Competitors
Table 19. Applied Biosystems Group Major Business
Table 20. Applied Biosystems Group DNA Diagnostics/Testing Product and Solutions
Table 21. Applied Biosystems Group DNA Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Illumina Inc. Corporate Information, Head Office, and Major Competitors
Table 23. Illumina Inc. Major Business
Table 24. Illumina Inc. DNA Diagnostics/Testing Product and Solutions
Table 25. Illumina Inc. DNA Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Cepheid Inc. Corporate Information, Head Office, and Major Competitors
Table 27. Cepheid Inc. Major Business
Table 28. Cepheid Inc. DNA Diagnostics/Testing Product and Solutions
Table 29. Cepheid Inc. DNA Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Hologic Corporate Information, Head Office, and Major Competitors
Table 31. Hologic Major Business
Table 32. Hologic DNA Diagnostics/Testing Product and Solutions
Table 33. Hologic DNA Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 35. Bio-Rad Laboratories Major Business
Table 36. Bio-Rad Laboratories DNA Diagnostics/Testing Product and Solutions
Table 37. Bio-Rad Laboratories DNA Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Dako Corporate Information, Head Office, and Major Competitors
Table 39. Dako Major Business
Table 40. Dako DNA Diagnostics/Testing Product and Solutions
Table 41. Dako DNA Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Abbott Corporate Information, Head Office, and Major Competitors
Table 43. Abbott Major Business
Table 44. Abbott DNA Diagnostics/Testing Product and Solutions
Table 45. Abbott DNA Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Roche Diagnostics Corporate Information, Head Office, and Major Competitors
Table 47. Roche Diagnostics Major Business
Table 48. Roche Diagnostics DNA Diagnostics/Testing Product and Solutions
Table 49. Roche Diagnostics DNA Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Beckman Coulter Inc. Corporate Information, Head Office, and Major Competitors
Table 51. Beckman Coulter Inc. Major Business
Table 52. Beckman Coulter Inc. DNA Diagnostics/Testing Product and Solutions
Table 53. Beckman Coulter Inc. DNA Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Siemens Healthcare Corporate Information, Head Office, and Major Competitors
Table 55. Siemens Healthcare Major Business
Table 56. Siemens Healthcare DNA Diagnostics/Testing Product and Solutions
Table 57. Siemens Healthcare DNA Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Global DNA Diagnostics/Testing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 59. Global DNA Diagnostics/Testing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 60. Breakdown of DNA Diagnostics/Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. DNA Diagnostics/Testing Players Head Office, Products and Services Provided
Table 62. DNA Diagnostics/Testing Mergers & Acquisitions in the Past Five Years
Table 63. DNA Diagnostics/Testing New Entrants and Expansion Plans
Table 64. Global DNA Diagnostics/Testing Revenue (USD Million) by Type (2017-2022)
Table 65. Global DNA Diagnostics/Testing Revenue Share by Type (2017-2022)
Table 66. Global DNA Diagnostics/Testing Revenue Forecast by Type (2023-2028)
Table 67. Global DNA Diagnostics/Testing Revenue by Application (2017-2022)
Table 68. Global DNA Diagnostics/Testing Revenue Forecast by Application (2023-2028)
Table 69. North America DNA Diagnostics/Testing Revenue by Type (2017-2022) & (USD Million)
Table 70. North America DNA Diagnostics/Testing Revenue by Type (2023-2028) & (USD Million)
Table 71. North America DNA Diagnostics/Testing Revenue by Application (2017-2022) & (USD Million)
Table 72. North America DNA Diagnostics/Testing Revenue by Application (2023-2028) & (USD Million)
Table 73. North America DNA Diagnostics/Testing Revenue by Country (2017-2022) & (USD Million)
Table 74. North America DNA Diagnostics/Testing Revenue by Country (2023-2028) & (USD Million)
Table 75. Europe DNA Diagnostics/Testing Revenue by Type (2017-2022) & (USD Million)
Table 76. Europe DNA Diagnostics/Testing Revenue by Type (2023-2028) & (USD Million)
Table 77. Europe DNA Diagnostics/Testing Revenue by Application (2017-2022) & (USD Million)
Table 78. Europe DNA Diagnostics/Testing Revenue by Application (2023-2028) & (USD Million)
Table 79. Europe DNA Diagnostics/Testing Revenue by Country (2017-2022) & (USD Million)
Table 80. Europe DNA Diagnostics/Testing Revenue by Country (2023-2028) & (USD Million)
Table 81. Asia-Pacific DNA Diagnostics/Testing Revenue by Type (2017-2022) & (USD Million)
Table 82. Asia-Pacific DNA Diagnostics/Testing Revenue by Type (2023-2028) & (USD Million)
Table 83. Asia-Pacific DNA Diagnostics/Testing Revenue by Application (2017-2022) & (USD Million)
Table 84. Asia-Pacific DNA Diagnostics/Testing Revenue by Application (2023-2028) & (USD Million)
Table 85. Asia-Pacific DNA Diagnostics/Testing Revenue by Region (2017-2022) & (USD Million)
Table 86. Asia-Pacific DNA Diagnostics/Testing Revenue by Region (2023-2028) & (USD Million)
Table 87. South America DNA Diagnostics/Testing Revenue by Type (2017-2022) & (USD Million)
Table 88. South America DNA Diagnostics/Testing Revenue by Type (2023-2028) & (USD Million)
Table 89. South America DNA Diagnostics/Testing Revenue by Application (2017-2022) & (USD Million)
Table 90. South America DNA Diagnostics/Testing Revenue by Application (2023-2028) & (USD Million)
Table 91. South America DNA Diagnostics/Testing Revenue by Country (2017-2022) & (USD Million)
Table 92. South America DNA Diagnostics/Testing Revenue by Country (2023-2028) & (USD Million)
Table 93. Middle East & Africa DNA Diagnostics/Testing Revenue by Type (2017-2022) & (USD Million)
Table 94. Middle East & Africa DNA Diagnostics/Testing Revenue by Type (2023-2028) & (USD Million)
Table 95. Middle East & Africa DNA Diagnostics/Testing Revenue by Application (2017-2022) & (USD Million)
Table 96. Middle East & Africa DNA Diagnostics/Testing Revenue by Application (2023-2028) & (USD Million)
Table 97. Middle East & Africa DNA Diagnostics/Testing Revenue by Country (2017-2022) & (USD Million)
Table 98. Middle East & Africa DNA Diagnostics/Testing Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. DNA Diagnostics/Testing Picture
Figure 2. Global DNA Diagnostics/Testing Revenue Market Share by Type in 2021
Figure 3. PCR Based Diagnostics
Figure 4. NGS DNA Diagnosis
Figure 5. In-situ Hybridization Diagnostics
Figure 6. Micro-arrays Based Diagnostics
Figure 7. DNA Diagnostics/Testing Revenue Market Share by Application in 2021
Figure 8. Oncology Diagnostics & Histopathology Picture
Figure 9. Identity Diagnostics & Forensics Picture
Figure 10. Pharmacogenomics Diagnostic Testing & Drug Metabolism Picture
Figure 11. Global DNA Diagnostics/Testing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global DNA Diagnostics/Testing Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global DNA Diagnostics/Testing Revenue Market Share by Region (2017-2028)
Figure 14. Global DNA Diagnostics/Testing Revenue Market Share by Region in 2021
Figure 15. North America DNA Diagnostics/Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe DNA Diagnostics/Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific DNA Diagnostics/Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America DNA Diagnostics/Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa DNA Diagnostics/Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. DNA Diagnostics/Testing Market Drivers
Figure 21. DNA Diagnostics/Testing Market Restraints
Figure 22. DNA Diagnostics/Testing Market Trends
Figure 23. Abbott Laboratories Recent Developments and Future Plans
Figure 24. Affymetrix Inc. Recent Developments and Future Plans
Figure 25. Agilent Technologies Inc Recent Developments and Future Plans
Figure 26. Applied Biosystems Group Recent Developments and Future Plans
Figure 27. Illumina Inc. Recent Developments and Future Plans
Figure 28. Cepheid Inc. Recent Developments and Future Plans
Figure 29. Hologic Recent Developments and Future Plans
Figure 30. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 31. Dako Recent Developments and Future Plans
Figure 32. Abbott Recent Developments and Future Plans
Figure 33. Roche Diagnostics Recent Developments and Future Plans
Figure 34. Beckman Coulter Inc. Recent Developments and Future Plans
Figure 35. Siemens Healthcare Recent Developments and Future Plans
Figure 36. Global DNA Diagnostics/Testing Revenue Share by Players in 2021
Figure 37. DNA Diagnostics/Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 38. Global Top 3 Players DNA Diagnostics/Testing Revenue Market Share in 2021
Figure 39. Global Top 10 Players DNA Diagnostics/Testing Revenue Market Share in 2021
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 41. Global DNA Diagnostics/Testing Revenue Share by Type in 2021
Figure 42. Global DNA Diagnostics/Testing Market Share Forecast by Type (2023-2028)
Figure 43. Global DNA Diagnostics/Testing Revenue Share by Application in 2021
Figure 44. Global DNA Diagnostics/Testing Market Share Forecast by Application (2023-2028)
Figure 45. North America DNA Diagnostics/Testing Sales Market Share by Type (2017-2028)
Figure 46. North America DNA Diagnostics/Testing Sales Market Share by Application (2017-2028)
Figure 47. North America DNA Diagnostics/Testing Revenue Market Share by Country (2017-2028)
Figure 48. United States DNA Diagnostics/Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Canada DNA Diagnostics/Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Mexico DNA Diagnostics/Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Europe DNA Diagnostics/Testing Sales Market Share by Type (2017-2028)
Figure 52. Europe DNA Diagnostics/Testing Sales Market Share by Application (2017-2028)
Figure 53. Europe DNA Diagnostics/Testing Revenue Market Share by Country (2017-2028)
Figure 54. Germany DNA Diagnostics/Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. France DNA Diagnostics/Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. United Kingdom DNA Diagnostics/Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Russia DNA Diagnostics/Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Italy DNA Diagnostics/Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Asia-Pacific DNA Diagnostics/Testing Sales Market Share by Type (2017-2028)
Figure 60. Asia-Pacific DNA Diagnostics/Testing Sales Market Share by Application (2017-2028)
Figure 61. Asia-Pacific DNA Diagnostics/Testing Revenue Market Share by Region (2017-2028)
Figure 62. China DNA Diagnostics/Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan DNA Diagnostics/Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South Korea DNA Diagnostics/Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India DNA Diagnostics/Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia DNA Diagnostics/Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia DNA Diagnostics/Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America DNA Diagnostics/Testing Sales Market Share by Type (2017-2028)
Figure 69. South America DNA Diagnostics/Testing Sales Market Share by Application (2017-2028)
Figure 70. South America DNA Diagnostics/Testing Revenue Market Share by Country (2017-2028)
Figure 71. Brazil DNA Diagnostics/Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina DNA Diagnostics/Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East and Africa DNA Diagnostics/Testing Sales Market Share by Type (2017-2028)
Figure 74. Middle East and Africa DNA Diagnostics/Testing Sales Market Share by Application (2017-2028)
Figure 75. Middle East and Africa DNA Diagnostics/Testing Revenue Market Share by Country (2017-2028)
Figure 76. Turkey DNA Diagnostics/Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia DNA Diagnostics/Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. UAE DNA Diagnostics/Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
